These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 6169172

  • 1. Platelet activation in myeloproliferative disorders.
    Cortelazzo S, Viero P, Barbui T.
    Thromb Haemost; 1981 Jun 30; 45(3):211-3. PubMed ID: 6169172
    [Abstract] [Full Text] [Related]

  • 2. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P, Cortelazzo S, Barbui T.
    Thromb Haemost; 1984 Jul 29; 51(3):411. PubMed ID: 6208631
    [No Abstract] [Full Text] [Related]

  • 3. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J.
    Thromb Haemost; 1984 Oct 31; 52(2):183-7. PubMed ID: 6084323
    [Abstract] [Full Text] [Related]

  • 4. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F, Luzzatto G, Girolami A.
    Thromb Haemost; 1985 Apr 22; 53(2):288-9. PubMed ID: 2410998
    [No Abstract] [Full Text] [Related]

  • 5. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P, Cortelazzo S, Bassan R, Barbui T.
    Thromb Haemost; 1982 Oct 29; 48(2):125-6. PubMed ID: 6184841
    [Abstract] [Full Text] [Related]

  • 6. In vivo platelet release in myeloproliferative disorders.
    Ireland H, Lane DA, Wolff S, Foadi M.
    Thromb Haemost; 1982 Aug 24; 48(1):41-5. PubMed ID: 6215739
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet function studies in myeloproliferative disorders.
    Pfliegler G, Boda Z, Udvardy M, Kiss A, Telek B, Pecze K, Nagy P, Rak K.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Aug 24; 113(5):655-62. PubMed ID: 2435631
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
    Ferri GM, Afeltra A, Caccavo D, Amoroso A.
    Recenti Prog Med; 1986 Jan 24; 77(1):31-2. PubMed ID: 2422709
    [No Abstract] [Full Text] [Related]

  • 14. Enhanced "in vitro" release of platelet alpha-granules after acute myocardial infarction (AMI).
    Pengo V, Boschello M, Prandoni P, Schiavon R, Bellotto F, Schivazappa L, Dalla Volta S.
    Thromb Haemost; 1985 Aug 30; 54(2):544-6. PubMed ID: 2934859
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
    Lokiec F, Najean Y.
    Nouv Presse Med; 1980 Oct 18; 9(38):2833-4, 2837-8. PubMed ID: 6160454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.